Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis

Cytometry

Volumn 24, Issue 3, 1996, Pages 260-267

  Glogovac, Jeri K ^a   Porter, Peggy L ^a,b   Banker, Deborah E ^b   Rabinovitch, Peter S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cell cycle; Cytokeratin; Ploidy; S phase

Indexed keywords

CYTOKERATIN; PARAFFIN;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; TUMOR CELL;

ANEUPLOIDY; BREAST NEOPLASMS; COLLAGENASES; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; KERATINS; PARAFFIN EMBEDDING; PEPSIN A;

EID: 0029682251     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960701)24:3<260::AID-CYTO9>3.0.CO;2-L     Document Type: Article

References (20)

1. Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE, Rabinovich PS: Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14:486-491, 1993.
2. Frei JV, Martinez VJ: DNA flow cytometry of fresh and paraffin-embedded tissue using cytokeratin staining. Mod Pathol 6:599-605, 1993.
3. Frei JV, Rizkalla K, Martinez VJ: Proliferative cell Indices measured by DNA flow cytometry in node negative adenocarcinoma of the breast; Accuracy and significance in cytokeratin stained archival specimens. Mod Pathol 7:925-992, 1994.
4. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335, 1983.
5. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D: Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14:482-485, 1993.
6. Kimmig R, Kapsner T, Spelberg H, Untch M, Hepp H: DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells. J Cancer Res Clin Oncol 121:107-114, 1995.
7. Leers MPG, Theunissen PHMH, Schutte B, Ramaekers FCS: Bivariate cytokeratin/DNA flow cytometric analysis of paraffin-embedded samples from colorectal carcinomas. Cytometry 21:101-107, 1995.
8. Makin CA, Bobrow LG, Bodmer WF: Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol 37:975-983, 1984.
9. Nylander K, Stenling R, Gustafsson H, Roos G: Application of dual parameter analysis in flow cytometric DNA measurements of paraffin embedded samples. J Oral Pathol Med 23:190-192, 1994.
10. Park CH, Kimler BF: Tumor cell-selective How cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating." Anticancer Res 14:29-36, 1994.
11. Ramaekers FCS, Beck HLM, Feitz WFJ, Oud PS, Debruyne FMJ, Vooijs GP, Herman CJ: Application of antibodies to intermediate filament proteins as tissue-specific probes in the flow cytometric analysis of complex tumors. Anal Quant Cytol Histol 8(4):271-280, 1986.
12. Shankey TV, Rabinovitch PS, Bagwell CB, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless LL: Guidelines for Implementation of Clinical DNA Cytometry. Cytometry 14:472-477, 1993.
13. Shankey TV, Kallioniemi OP, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ: Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14:497-500, 1993.
14. Visscher DW, Zarbo RJ, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman JD: Multiparameter deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Lab Invest 62:370-378, 1990.
15. Visscher DW, Wykes S, Zarbo RJ, Crissman JD: Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas. Anal Quant Cytol Histol 13:246-252, 1991.
16. Wheeless LL, Badalament RA, deVere White RW, Fradet Y, Tribukait B: Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14:478-481, 1993.
17. Wingren S, Stal O, Carstensen J, Sun X, Nordenskjold B: S- phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence. Breast Cancer Res Treat 29:179-187, 1993.
18. Wingren S, Stal O, Nordenskjold B: Flow cytometric analysis of S phase fraction in breast carcinomas using gating on cells containing cytokeratin. Br J Cancer. 69:546-549, 1994.
19. Wingren S, Stal O, Sullivan S, Brisfors A, Nordenskjold B: S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer. Int J Cancer 59:7-10, 1994.
20. Zarbo RJ, Visscher DW, Crissman JD: Two-color multiparameter method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 11:391-402, 1989.